In many cases, extracellular HMGB1 acts as a pro-tumor protein due to its cytokine, chemokine, and growth factor activity, whereas intracellular HMGB1 promotes drug resistance owing to the pro-autophagy activity and regulation of gene transcription (28–30). This evidence concerns the gene HMGB1 and neoplasm.